- Home
- CODA vs CNTB Comparison
CODA vs CNTB Comparison
Compare CODA & CNTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CODA
- CNTB
- Stock Information
- Founded
- CODA 1994
- CNTB 2012
- Country
- CODA United States
- CNTB United States
- Employees
- CODA N/A
- CNTB N/A
- Industry
- CODA Industrial Machinery/Components
- CNTB Biotechnology: Pharmaceutical Preparations
- Sector
- CODA Industrials
- CNTB Health Care
- Exchange
- CODA Nasdaq
- CNTB Nasdaq
- Market Cap
- CODA 88.8M
- CNTB 93.9M
- IPO Year
- CODA N/A
- CNTB 2021
- Fundamental
- Price
- CODA $7.97
- CNTB $2.98
- Analyst Decision
- CODA
- CNTB Strong Buy
- Analyst Count
- CODA 0
- CNTB 3
- Target Price
- CODA N/A
- CNTB $8.33
- AVG Volume (30 Days)
- CODA 73.5K
- CNTB 431.5K
- Earning Date
- CODA 09-15-2025
- CNTB 11-12-2025
- Dividend Yield
- CODA N/A
- CNTB N/A
- EPS Growth
- CODA 15.09
- CNTB N/A
- EPS
- CODA 0.30
- CNTB N/A
- Revenue
- CODA $24,347,217.00
- CNTB $762,000.00
- Revenue This Year
- CODA $30.82
- CNTB N/A
- Revenue Next Year
- CODA $20.84
- CNTB $453,067.90
- P/E Ratio
- CODA $27.13
- CNTB N/A
- Revenue Growth
- CODA 29.34
- CNTB N/A
- 52 Week Low
- CODA $5.76
- CNTB $0.51
- 52 Week High
- CODA $10.54
- CNTB $3.21
- Technical
- Relative Strength Index (RSI)
- CODA 39.59
- CNTB 77.95
- Support Level
- CODA $7.80
- CNTB $1.49
- Resistance Level
- CODA $8.39
- CNTB $3.21
- Average True Range (ATR)
- CODA 0.43
- CNTB 0.29
- MACD
- CODA -0.14
- CNTB 0.17
- Stochastic Oscillator
- CODA 17.71
- CNTB 88.54
About CODA Coda Octopus Group Inc. Common stock
Coda Octopus Group Inc develops underwater technologies and equipment for imaging, mapping defense, and survey applications. The company's operations are organized into two reportable segments: the Products Segment (Marine Technology Business serving the subsea market and PAL, which sells other products (acoustic hydrophones and acoustic materials to a different market); and the Services Segment (Marine Engineering Business). Its geographical segments are the Americas, Europe, Australia/Asia, and the Middle East/Africa. The majority of revenue is derived from the Products segment.
About CNTB Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.